Matthew Rabinowitz $NTRA SEC Form 4 Insider Trading

Matthew Rabinowitz has filed a total of 29 insider trades in $NTRA since 2021. Their most recent trade was a sale of 28,681 shares, made on Dec 13, 2024. Their largest trade was a purchase of 159,783 shares, made on May 12, 2022. We estimate that they now own 2.5 million shares of $NTRA, worth an estimated $416.6 million.

Insider Trading at $NTRA

There have been a total of 607 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 3.0 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 1 shares reported by John Fesko (PRESIDENT, CHIEF BUS. OFFICER), made on Dec 23, 2024.

$NTRA Executives and Stock Owners with Insider Trades

• Steven Leonard Chapman, CEO AND PRESIDENT

• Michael Burkes Brophy, CHIEF FINANCIAL OFFICER

• Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER

• Robert Alan Schueren, CHIEF OPERATING OFFICER

• Matthew Rabinowitz, EXECUTIVE CHAIRMAN

• Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS

• John Fesko, PRESIDENT, CHIEF BUS. OFFICER

• Daniel Rabinowitz, CHIEF LEGAL OFFICER

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.